America approves ‘revolutionary’ CAR T cell immunotherapy — what does this mean for cancer patients?

The decision by US regulators to approve this first-of-its-kind treatment has been hailed as ‘historic’ and ‘a new frontier’ in cancer treatment. But how significant is the announcement by US regulators – and will it make-it across the pond?
Institute of Cancer Research